Early response to therapy and survival in multiple myeloma.

Schaar, C G; Kluin-Nelemans, J C; le Cessie, S; Franck, P F H; te Marvelde, M C; Wijermans, P W

Schaar, C G; Kluin-Nelemans, J C; le Cessie, S; Franck, P F H; te Marvelde, M C; Wijermans, P W.

Affiliation

Schaar CG; Department of Haematology, Leiden University Medical Centre, Leiden, The Netherlands. c.schaar@gelre.nl

Br J Haematol ; 125(2): 162-6, 2004 Apr.

Article in En | MEDLINE | ID: mdl-15059138

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Multiple Myeloma/drug therapy; Adult; Aged; Aged, 80 and over; Female; Humans; Immunoglobulin A/metabolism; Immunoglobulin G/metabolism; Male; Melphalan/administration & dosage; Middle Aged; Multiple Myeloma/metabolism; Myeloma Proteins/metabolism; Prednisone/administration & dosage; Prospective Studies; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Multiple Myeloma Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2004 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links